| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $32.49B | $30.73B | $34.71B |
| YoY Revenue Growth % | +5.7% | -11.5% | — |
| Gross Profit | $3.88B | $4.10B | — |
| Gross Margin % | 11.9% | 13.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.06B | $2.39B | $5.34B |
| Operating Margin % | 6.3% | 7.8% | 15.4% |
| Net Income (GAAP) | $1.74B | $2.03B | $4.53B |
| EBITDA (Normalized) | $4.80B | $4.93B | $6.59B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.23B | $3.98B | $7.11B |
| Capital Expenditures (CapEx) | $3.42B | $3.17B | $1.56B |
| Free Cash Flow (FCF) | -$188.0M | $806.0M | $5.55B |
| FCF Margin % | -0.6% | 2.6% | 16.0% |
| Return on Invested Capital (ROIC %) | 6.6% | 8.4% | 16.8% |
| Cash & Short-Term Equivalents | $2.26B | $3.56B | — |
| Total Debt (Short + Long Term) | $5.84B | $5.64B | $9.75B |
| Total Stockholders' Equity | $20.94B | $20.29B | $20.00B |